Trump signs Medicaid-slashing budget into law

Описание: In today’s headlines - 7 July 2025:

Trump's One Big Beautiful Bill Act is signed into law, and commentators are gauging its impact on healthcare insurance coverage.

J&J is hoping the AMPLITUDE study results will make Akeega the first drug in the PARP inhibitor class for castration-sensitive prostate cancer.

KalVista has brought the first oral, on-demand treatment for hereditary angioedema attacks to the US market.

Apogee shares have spiked on data showing strong efficacy with its atopic dermatitis drug – and maybe dosing of just two to four injections a year.

Find out why two medical charities have issued a call to the UK government to remove obstacles that they say impede R&D into rare diseases and access to new therapies.

Subscribe to ‪@Pharmaphorum‬ for daily news updates and check out www.pharmaphorum.com for more insights and analysis.

#pharmanews #lifescience #pharmainnovation #biotechnews #healthcarenews #ukhealthcare #rarediseaseresearch #apogee #atopicdermatitis #kalvista #angioedema #parpinhibitor #prostatecancertreatment #johnsonandjohnson #ushealthcare #usgovernment #bigbeautifulbill #medicare2025 #healthinsurance #drugpricing #trumpadministration